Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announces the completion of its acquisition of Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey, marking an expansion of the companies’ strategic partnership to enable additional U.S. drug product manufacturing. The Ridgefield facility is now part of Thermo Fisher’s pharma services business within its Laboratory Products and Biopharma Services segment. Under the agreement, Thermo Fisher will continue to manufacture a portfolio of therapies for Sanofi at the Ridgefield site while expanding use of the site to meet the growing demand for U.S. manufacturing capacity from pharma and biotech customers.
Read the full article: Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site //
Source: https://www.businesswire.com/news/home/20250902260773/en/Thermo-Fisher-Scientific-Completes-Acquisition-of-Sanofis-Ridgefield-New-Jersey-Site